Hematopoietic stem cell transplantation in multiple sclerosis: A review of the clinical experience and a report of an international meeting

Expert Review of Clinical Immunology

Volumn 6, Issue 3, 2010, Pages 347-352

  Karussis, Dimitrios ^a   Vaknin Dembinsky, Adi ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERFERON; MELPHALAN; METHYLPREDNISOLONE; MITOXANTRONE; SUPERPARAMAGNETIC IRON OXIDE; TENIPOSIDE; THYMOCYTE ANTIBODY;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CLINICAL TRIAL; CONFERENCE PAPER; DIARRHEA; DRUG EFFECT; DRUG FATALITY; GASTROINTESTINAL SYMPTOM; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; PYREXIA IDIOPATHICA; QUALITY OF LIFE; REGULATORY T LYMPHOCYTE; RESPIRATORY FAILURE; RHEUMATOID ARTHRITIS; SEPSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THERAPY EFFECT; UNSPECIFIED SIDE EFFECT; WHOLE BODY RADIATION;

ANIMALS; AUTOIMMUNE DISEASES; CLINICAL TRIALS AS TOPIC; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MULTIPLE SCLEROSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 77952012521     PISSN: 1744666X     EISSN: None     Source Type: Journal    
DOI: 10.1586/eci.10.7     Document Type: Conference Paper

References (10)

1. Mancardi G. Further data on autologous haemopoietic stem cell transplantation in multiple sclerosis. Lancet Neurol. 8 (3), 219-221 (2009).
2. Burt RK, Loh Y, Cohen B et al. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a Phase I/II study. Lancet Neurol. 8 (3), 244-253 (2009).
3. Karussis DM, Slavin S, Lehmann D, Mizrachi-Koll R, Abramsky O, Ben-Nun A. Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation. J. Immunol. 148 (6), 1693-1698 (1992).
4. van Gelder M, Kinwel-Bohré EP, van Bekkum DW. Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT. Bone Marrow Transplant. 11 (3), 233-241 (1993).
5. Marmont AM. Will hematopoietic stem cell transplantation cure human autoimmune diseases? J. Autoimmun. 30 (3), 145-150 (2008).
6. Fassas A, Anagnostopoulos A, Kazis A et al. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: frst results of a pilot study. Bone Marrow Transplant. 20 (8), 631-638 (1997).
7. Roccatagliata L, Rocca M, Valsasina P et al. The long-term effect of AHSCT on MRI measures of MS evolution: a fve-year follow-up study. Mult. Scler. 13 (8), 1068-1070 (2007).
8. Metz I, Lucchinetti CF, Openshaw H et al. Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis. Brain 130 (Pt 5), 1254-1262 (2007).
9. Hamerschlak N, Rodrigues M, Moraes DA et al. Brazilian experience with two conditioning regimens in patients with multiple sclerosis: BEAM/horse ATG and CY/rabbit ATG. Bone Marrow Transplant. 45 (2), 239-248 (2010).
10. Tyndall A, Saccardi R. Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from Phase I/II studies, prospective randomized trials and future directions. Clin. Exp. Immunol. 141 (1), 1-9 (2005).